Robert E. Ratner, MD, gave the opening presentation at the Avandia review with little news to report: diabetes incidence is expected to increase in this country, blood sugar control is hard to achieve even when tightly monitored, and medical costs are expected to increase by about $60B by 2020. We already knew these things. But what he... Read more
This place is a zoo. I've never seen anything like it: reporters stacked row after row with laptops, television cameras lined across the center of the room, satellite dishes as tall as me positioned outside. This is FDA hearing regarding the safety of popular diabetes drug Avandia, and judging by the hoopla in this Holiday Inn in... Read more
After more than a month of headlines bashing the effects of diabetes drug Avandia, the FDA will ask an advisory panel whether GlaxoSmithKline's drug should be taken off the U.S. market. The review will take place Monday morning in Gaithersburg, Md. Just today, another study was released claiming Avandia doubles the risk of heart... Read more
First it was a study on Avandia that caused a whirlwind with the media: the study said Avandia may lead to increased risk of heart attacks and death. Then, just a few days ago, we covered yet another study: that study said Avandia may cause weight gain and fluid retention. Now, today, a study has been released that says Avandia might increase the... Read more